Press releases – Enzymatica

September 4, 2019

Regulatory press release

Preliminary results of Enzymatica’s placebo-controlled, randomized study did not meet the primary end-point

August 26, 2019

Other press release

ColdZyme launches with new flavor and new product claims

July 17, 2019

Regulatory press release

Good growth in Q2, driven mainly by strong sales in Sweden

June 19, 2019

Regulatory press release

Enzymatica signs supply agreement with German cosmetic company Maren, amounting to a value of SEK 120 million over a period of three years

May 7, 2019

Regulatory press release

Bulletin from Annual General Meeting in Enzymatica AB (publ)

May 7, 2019

Regulatory press release

Continued strong growth in Sweden, but lower total sales during the quarter

May 3, 2019

Other press release

All patients enrolled in Enzymatica’s German placebo-controlled multicentre study with ColdZyme

April 16, 2019

Regulatory press release

Enzymatica’s cold spray launched in South Africa

February 19, 2019

Regulatory press release

Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany

January 30, 2019

Regulatory press release

Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme

January 25, 2019

Other press release

Multi-symptom Relief and Improvement of Quality of Life – A Comparative Multicenter Trial on ColdZyme® Mouth Spray in Common Cold

January 25, 2019

Regulatory press release

Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme’s product claims

Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.

OK